Business Context and Reporting Period
Company: MaxCyte, Inc. (MXCT)
Filing Type: Form 8-K (Current Report)
Date of Report: November 12, 2025
Reporting Period: The filing announces financial results for the quarter and nine months ended September 30, 2025. The company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The provided text is a cover sheet and index for the Form 8-K. It references a press release (Exhibit 99.1) containing the actual financial data but does not list specific figures within this document.
- Revenue, Profit, Cash Flow, Margins: Not provided in the filing text; contained in Exhibit 99.1.
- Debt and Liquidity: Not provided in the filing text; contained in Exhibit 99.1.
Material Changes
The filing text does not detail specific material changes in financial performance versus prior periods. It serves to notify the market of the release of results for the period ended September 30, 2025.
Guidance, Outlook, and Disclosures
- Regulation FD Disclosure: The company posted an updated corporate presentation to its investor website, available as Exhibit 99.2.
- Legal Status of Information: The information in this 8-K and its exhibits is furnished and not deemed "filed" under Section 18 of the Exchange Act. It is not incorporated by reference into other filings unless expressly stated.
- Management Commentary: Specific commentary is located in the referenced press release and corporate presentation, not in the 8-K text itself.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net loss, and cash position figures for the quarter and nine months ended September 30, 2025.
- Examine Exhibit 99.2 (Corporate Presentation) for updated strategic outlook and operational milestones.
- Verify the company's status as an emerging growth company and any associated reporting exemptions.
- Confirm the date of the financial results announcement (November 12, 2025) against market trading data.